Tests a whey protein drink on blood sugar in night shift workers
Tests whey protein against a placebo in night shift workers with type 2 diabetes.
Plain-language title generated from the registry record
Registry title: Effects of an Evening PROtein PrEload on Metabolic Health in Night ShIfT Workers (PROPENSITy)
Key facts
- Where
- Adelaide, AustraliaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 35 and 65 years old?
Source: NCT04869098, who can take part
Where in Australia
- University of AdelaideAdelaide, AustraliaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Adelaide
- Trial code
- NCT04869098
- Record updated
- 24 December 2024
- Original description
This study will compare the effects of a whey protein supplement or a placebo consumed before the evening meal on health outcomes in night shift workers.Read full original descriptionShow less
Effects of an Evening PROtein PrEload on Blood Glucose, Metabolic Health, and Gut Hormone Release in Night ShIfT Workers (PROPENSITy)
This study will compare the effects of a whey protein supplement or a placebo consumed before the evening meal on health outcomes in night shift workers.
Inclusion: Female; Night shift workers (with a minimum of 6 months in their current shift work schedule); 35-65 years; BMI 28.0-35.0 kg/m2; waist circumference > 80cm; Weight stable in the past 6 months.
Exclusion: Personal history and/or diagnosis of: diabetes, cancer, major psychiatric disorders, liver disease, gastro-intestinal surgery or disease (including malabsorption), eating disorders, anaemia, insomnia or cardiovascular disease, and/or any other condition deemed unstable by the study physician; Participants who are taking stable doses (i.e. > 12 months) of androgenic medications (i.e. testosterone) or SSRI's will not be excluded. Personal history/diagnosis (self-reported) of diabetes (type 1 or 2), major psychiatric disorders (schizophrenia, major depressive disorder, bipolar disorder, eating disorders), gastrointestinal disorders, haematological disorders (i.e. thalassemia, iron-deficiency anaemia) insomnia, or any other medical condition, deemed unstable by the study physician; Taking medications known to alter body composition or metabolism, including (but not limited to): any medication used to lower blood glucose or antidiabetic medications (metformin, sulfonylureas, Glucagon-like peptide-1 (GLP-1) analogues [i.e. exenatide], thiazolidinediones or DPP-IV inhibitors [i.e. 'gliptins']), medications affecting weight, appetite or gut motility (i.e. diuretics, domperidone, cisapride, orlistat, phentermine, topiramate); Those working standard day time hours only, or those who work less than three to four night shifts per fortnight on average; Pregnant, planning a pregnancy or breastfeeding; Those who have lost or gained >5% of body weight in the last 6 months; Those who consume four or more standard drinks on a single occasion at a 'daily or almost daily' occurrence; current smokers of cigarettes/marijuana/e-cigarettes/vaporisers; unable to comprehend the study protocol (i.e. due to English language or cognitive difficulties).